AZ divests Atrium Oncology unit
AstraZeneca has completed the sale of the assets of its subsidiary, Aptium Oncology. - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/az_divests_atrium_oncology_unit_977000
Search results
Found 5,211 pages
AUTHOR: Kevin Grogan
Amgen biosimilar matches Humira in RA trial
Amgen’s biosimilar of Humira has shown comparable efficacy for moderate-to-severe rheumatoid arthritis in a late-stage trial with AbbVie’s branded inflammatory blockbuster - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/amgen_biosimilar_matches_humira_in_ra_trial_970984Roche signs Parkinson's pact with 23andMe
Roche’s Genentech unit has linked up with personal genetics company 23andMe to identify new therapeutic targets for Parkinson’s disease. - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/roche_signs_parkinsons_pact_with_23andme_970837FDA panel mixed on Dynavax hepatitis vaccine
Advisors to the US Food and Drug Administration have backed the efficacy of Dynavax' hepatitis B vaccine Heplisav but expressed concerns about its safety profile. - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/fda_panel_mixed_on_dynavax_hepatitis_vaccine_976217Otsuka tests drug for childhood TB
Otsuka Pharmaceutical Co says that enrollment has begun for "a ground-breaking clinical programme" looking at its investigational drug delamanid for paediatric multidrug-resistant tuberculosis (MDR-TB). - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/otsuka_tests_drug_for_childhood_tb_1005351B-MS inks fibrosis pact with Calibr
Bristol-Myers Squibb has linked up with the California Institute for Biomedical Research to develop anti-fibrotic therapies. - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/b-ms_inks_fibrosis_pact_with_calibr_970805Sanofi and BI ink biologics manufacturing deal
Sanofi has signed up Boehringer Ingelheim as its partner to manufacture monoclonal antibodies. - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/sanofi_and_bi_ink_biologics_manufacturing_deal_970872Shire extends offer for ViroPharma again
Shire has extended its tender offer to buy ViroPharma for a second time, now expiring on midnight January 23. - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/shire_extends_offer_for_viropharma_again_1001342Teva gets FDA OK for generic Combivir
Teva Pharmaceutical Industries has been granted the first approval to market a generic version of the HIV drug Combivir. - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/teva_gets_fda_ok_for_generic_combivir_980970Nestle pact with stem cell biotech CDI
Food giant Nestle has linked up with USA-based stem cell specialist Cellular Dynamics International. - News - PharmaTimes
by Kevin Grogan
www.pharmatimes.com/news/nestle_pact_with_stem_cell_biotech_cdi_1001327
